PMVP PMV Pharmaceuticals, Inc.
Healthcare$1.27+0.00%OpenMarket Cap: $67.5M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.76
P/S
0.00
EV/EBITDA
-0.35
DCF Value
$0.65
FCF Yield
-111.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-69.0%
ROA
-81.1%
ROIC
-94.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-19.0M | $-18.0M | $— | — |
| Q4 null | $0.00 | NaN% | $-19.2M | $-18.0M | $— | — |
| FY null | $0.00 | NaN% | $-86.2M | $-77.7M | $— | — |
| Q3 null | $0.00 | NaN% | $-22.5M | $-21.1M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-22.9M | $-21.2M | $— | — |
| Q1 null | $0.00 | NaN% | $-21.6M | $-17.4M | $— | — |
| Q4 null | $0.00 | NaN% | $-25.2M | $-23.0M | $— | — |
| FY null | $0.00 | -Infinity% | $-85.4M | $-58.7M | $— | — |
| Q3 null | $0.00 | NaN% | $-21.9M | $-19.2M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-20.2M | $-1.2M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-18.2M | $-15.3M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-18.9M | $-15.8M | $-0.31 | — |